Novo Nordisk's diabetes drug, Ozempic, receives positive CHMP opinion in the EU for expanded use in T2D and CKD patients.
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Rubriques :
Maroc - HAEI.ORG - A La Une - 13/Dec 12:37
CSL Receives Positive CHMP Opinion for Garadacimab in HAE
CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE) CSL announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending granting a marketing authorization for garadacimab as a once-monthly prophylactic treatment for hereditary angioedema (HAE) in adult and adolescent patients aged 12 years [...]
Articles similaires
Astria announces positive final results from target enrollment in the ALPHA-STAR Phase 1b/2 trial of navenibart for HAE
haei.org - 11/Dec 08:27
Astria Therapeutics announces positive final results from target enrollment in the ALPHA-STAR Phase 1b/2 trial of navenibart for HAE Astra...
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
zacks.com - 16/Dec 18:40
The CHMP recommends the approval of Gilead's seladelpar in combination with ursodeoxycholic acid for the treatment of primary biliary cholangitis in...
Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti
times of india - 16/Dec 16:41
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat...
Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti
times of india - 16/Dec 16:41
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat...
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications
zacks.com - 16/Dec 15:57
The CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated with renal cell carcinoma.
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
drugs.com - 12/Dec 04:12
SAN FRANCISCO--(BUSINESS WIRE) December 12, 2024 -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that tobevibart and elebsiran have received...
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
drugs.com - 12/Dec 04:12
SAN FRANCISCO--(BUSINESS WIRE) December 12, 2024 -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that tobevibart and elebsiran have received...
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
zacks.com - 17/Dec 15:43
The CHMP recommends marketing approval to GSK's Vocabria plus JNJ's Rekambys for treating HIV-1 infection in adolescents aged 12 years and older.
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
zacks.com - 16/Dec 12:23
The CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn's disease patients with or without prior biologic...
Les derniers communiqués
-
Aucun élément